Media & Events
Keep up to date with the latest updates in ECRAID and the development of the business plan.
For any media inquiries, please contact ECRAID-Plan’s communications team.
PRESS RELEASE: Tocilizumab effective in treating sickest COVID-19 patients
UMC UTRECHT & IMPERIAL COLLEGE LONDON PRESS RELEASE Critically ill patients with COVID-19 treated with a drug that...Read more
Smart, Innovative, Continuous: REMAP-CAP Launches First Video
ECRAID is an initiative from PREPARE and COMBACTE and involves key partners from both consortia. The clinicial research...Read more
ECRAID-Plan network partners met in Amsterdam for the third iteration in developing the business plan
On Tuesday 10 December 2019, the network partners of ECRAID-Plan met in Amsterdam Schiphol for an interesting discussion...Read more